Form 4 holding
Director, 10%+ Owner
Aerovate Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 12,500
- Estimated value
- $204,625
- Report date
- 05 Jun 2024
- Price
- $16.37
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount